Scientific Programme. Thursday 9 November Day 1. Venue: Century City Conference Centre. FIDSSA Official Opening Ceremony

Size: px
Start display at page:

Download "Scientific Programme. Thursday 9 November Day 1. Venue: Century City Conference Centre. FIDSSA Official Opening Ceremony"

Transcription

1 Thursday 9 November Day 1 Scientific Programme : Century City Conference Centre 15h00 19h00 Conference Registration FIDSSA Official Opening Ceremony Halls B & C 17h00 17h15 Welcome and Opening Marc Mendelson (FIDSSA President) PLENARY SESSION 1: Emerging and Re-Emerging Infectious Diseases (In partnership with ISID) Chair: Lucille Blumberg 17h15 17h45 17h45 18h15 18h15 18h45 African viruses flourishing in the diaspora Margheretta Isaacson Lecture Oyewale Tomori (Nigeria) Surveillance of emerging and re-emerging infectious diseases Larry Madoff (USA) The cost of delaying measles eradication David Durrheim (Australia) 18h45 21h00 Welcome Function & Trade Preview Exhibition Area

2 Scientific Programme Friday 10 November Day 2 Meet the IPC Nursing Expert Takeda Breakfast Symposium NICD Breakfast Symposium Meeting Room 11 Hall A Meeting Room 10 07h00 07h45 Quality of our drinking water, wider implications of water shortage in South Africa on the hospital environment Nonhlanhla Kalebaila Optimising treatment in the current crisis Stephan Harbarth (Switzerland) New improved strategies for reporting Notifiable Medical Conditions in South Africa: 2017 and beyond Portia Mutevedzi PLENARY SESSION 2: Drug-Resistant Infections (In partnership with ESCMID) Chair: Adrian Brink 16 08h00 08h30 Halls B & C Management of infections due to MDR gram-negatives: towards individualised therapy Jesus Rodriguez-Bãno (Spain) 08h30 09h00 Neonatal sepsis and drug-resistant infections Mike Sharland (UK) 09h00 09h30 One health approach to drug-resistant infections Sabiha Essack 09h30 10h00 Promoting patient participation in the strategy to combat Antibiotic Resistance Vanessa Carter 10h00 10h30 Refreshments & Poster Viewing Exhibition Area

3 Friday 10 November PARALLEL SESSION 1 Hall A Hall B Hall C Meeting Room 11 SASPID HIV & TB: Infants, Co-Infection, Treatment Failure SASCM New Directions in Clinical Microbiology STDSSA The Alarming Sti Epidemic In South Africa: Can We Improve Current Management Strategies? SASTM Shifting And Overstepping Boundaries Nicolette du Plessis Brian Eley Warren Lowman Chetna Govind Ranmini Kularatne Heather Jaspan Salim Parker Lee Baker 10h30 12h30 Management of TB in neonates and young infants (2) Adrie Bekker Treatment of HIV/TB co-infection in children (2) Helen McIlleron Third line ART in children: how are we doing? (2) James Nuttall Epidemiology of influenza- and respiratory syncytial virus (RSV)-associated hospitalisation in children aged <5 years in a setting with high HIV prevalence, South Africa, Meredith McMorrow Culture-confirmed tuberculosis in infants less than 3 months of age: A clinical description of 71 cases Lisa Frigati Treatment outcomes in perinatally-hivinfected children and adolescents after 10 years on antiretroviral therapy Kim Anderson Routine microbiome analysis in the clinical microbiology laboratory: now or never? (2) Mark Nicol Treatment of ESBL and carbapenemase producing Enterobacteriaceae: A casebased (2) Jesus Rodriguez-Bãno (Spain) Innovative Stewardship (2) Sabiha Essack Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical-trauma intensive care unit Rispah Chomba Can we trust the Xperts? An evaluation of the Xpert MRSA/SA BC system and assessment of potential clinical impact Kessendri Reddy Investigation of discrepancies between phenotypic and molecular methods for detection rifampicin susceptibilities from a tertiary diagnostic laboratory in Pretoria: towards consensus in rpob mutations Kudzai Nyazema 2016 STI prevalence in young men and women in KwaZulu Natal (1) Nuala McGrath STI and BV prevalence in young women in Cape Town and Soweto (10 mins) Shaun Barnabas New South Africa STI and BV management guidelines (1) Koleka Mlisana Rapid/point-of-care diagnostic for STIs: Needs, progress and challenges (1) Ranmini Kularatne GeneXpert for POC STI testing in South Africa (10 mins) Nigel Garrett Cytokine biomarkers triage test for STIs and BV (10 mins) Lindi Masson Behavioural modification to reduce STI incidence in adolescent women (10 mins) Linzi Rabinowitz PANEL DISCUSSION: The way forward (3) Q. Abdool Karim, N. McGarth, K. Mlisana, R. Kularatne, N. Garrett, JA. Passmore Yellow Fever (2) Oyewale Tomori (Nigeria) Zoonosis (2) Emily Mitchell Medical Tourism beyond nip and tuck (2) Adriano Dusé Bytes and bites from Barcelona (2) Salim Parker, Garth Brink, Lee Baker Implementation of a mobile application for Hand Hygiene monitoring: Smart, Simple and Interactive Angeliki Messina Odyssean malaria outbreak at a bush lodge in Madikwe Game Reserve, North West Province, October-November 2015 Genevie Ntshoe 12h30 13h30 Refreshments & Poster Viewing Exhibition Area

4 Friday 10 November PLENARY SESSION 3: Managing Infections in Adolescents and Pregnant Women Chair: Nelesh Govender 13h30 14h00 14h00 14h30 14h30 15h00 Halls B & C The intersection of HIV and NCD epidemics and clinical implications Mosepele Mosepele (Botswana) Adolescent vaccination strategies Greg Hussey Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa Quarrhaisha Abdool Karim 15h00 15h30 Refreshments & Poster Viewing Exhibition Area PARALLEL SESSION 2 Hall A Hall B Hall C Meeting Room 11 DR - TB - What s New? ICSSA Control of the Environment for IPC HIV Specific Challenges in HIV Management Management Systems in Rural Care Sean Wasserman Justyna Wojno Yolanda Walsh Lesley Devenish Yolanda van Zyl Halima Dawood Sipho Dlamini Tom Boyles Rosie Burton 18 15h30 17h30 The shorter regimen for MDR-TB: evidence and pitfalls (20 mins) Helen Cox Possibilities and challenges for a pan-tb regimen (20 mins) Robert Wallis Diagnostic discordance dilemma in TB Pitfalls and solutions (20 mins) Nazir Ismail The clinical pharmacology and drug interactions of Bedaquiline (20 mins) Helen McIlleron Introduction of drug resistant TB Reflex Testing in Kwa-Zulu Natal A descriptive analysis of MTBDRsl resistant isolates over a 9-month period Keeren Lutchminarain The incidence of discordant Rifampicin susceptibility results between genotypic and phenotypic methods in Mycobacterium tuberculosis complex isolates at Dr George Mukhari Hospital Tertiary Laboratory Caroline Maluleka Evaluation of methods for generation of in vitro mutants resistant to bedaquiline, clofazimine and linezolid from Mycobacterium tuberculosis reference strains Nabila Ismail Impact of effective treatment on TB transmission, lack of impact of XDR treatment on transmission, problem of reducing transmission in treatment failures (30 mins) Edward Nardell (USA) Limitations of natural ventilation and mechanical ventilation and room air cleaners in controlling airborne infection (30 mins) Tobias Van Reenen Environmental cleaning for persistent resistant organisms (20 mins) Marilyn Leadsom Importance of the environment; and newer technologies for environmental disinfection (20 mins) Adriano Dusé Risk assessment for the transmission of Infectious Diseases in the South African Police Services (SAPS) Lesley Devenish #CAUTI MUST FALL Shakiera Sallie Scaling up treatment for 7 million the innovations required (2) Ntombi Sigwebela Trailblazers: Lessons learned from the first ART programmes (2) Gary Maartens Cardiovascular disease in HIV (2) Loicea Achieng (Kenya) Current challenges of HIV research in children- where are the gaps while we wait for cure? (2) Helena Rabie The effects of the attributable fraction and the duration of symptoms on burden estimates of influenzaassociated respiratory illnesses in a high HIV-prevalence setting, South Africa, Stefano Tempia Strong association between higher risk sex and HIV prevalence at regional level: an ecological study of 27 sub-saharan African countries Chris Kenyon Austerity and healthcare delivery in rural areas: how do we set priorities? (2) Marije Versteeg-Mojanaga Challenges in caring for acutely ill AIDS patients in rural district hospitals (2) Hoffie Conradie Tackling the Hippo: Infectious diseases at household and community level in rural areas (2) Steve Reid Managing HIV resistance in a deeply rural setting. Can it be done? (2) Jenny Minnaar Prevalence and characterisation of food and waterborne bacterial pathogens in river water, meat from informal abattoirs, and stool from children with diarrhoea in Nyanga Township, Cape Town, South Africa John Bosco Kalule Outbreak preparedness and the NICD 24-hour hotline - a review of calls made to the hotline, August 2016-July 2017 Kerrigan McCarthy 17h30 18h30 ICSSA AGM IDSSA AGM STDSSA AGM SASPID AGM SASCM AGM SASTM AGM 18h30 19h15 FIDSSA AGM Hall B 19h30 Invited Faculty Dinner Delegates Evening At Leisure

5 Saturday 11 November Day 3 Trainee Session Beckman Coulter Breakfast Symposium Meeting Room 11 Hall A 07h00 07h45 Truth or Dare Meet the Expert Session for Trainees Panel Discussion Rob Davidson and Mosepele Mosepele Current Challenges and Emerging Resistance Detection in the Clinical Microbiology Laboratory Barbara Zimmer (USA) PLENARY SESSION 4 Spotlight on Infection Prevention Chair: Shaheen Mehtar 08h00 08h30 Hall B & C Prevention of hospital-acquired infections Stephan Harbarth (Switzerland) 08h30 09h00 Determining infectiousness in transmission for TB patients Edward Nardell (USA) 09h00 09h30 09h30 10h30 UVGI: New SA Guidelines Tobias van Reenen Poster Presentations Hall D Refreshments Exhibition Area

6 Saturday 11 November PARALLEL SESSION 3 Hall A Hall B Hall C Meeting Room 11 IDSSA New Insights into Viral Hepatitis Antimicrobial Research and Development (SAASP) Malaria / Tropical Vaccines John Black Wolfgang Preiser Marc Mendelson Adrian Brink John Frean Rob Davidson Gary Reubenson Sipho Dlamini 20 10h30 12h30 Why is the elimination of viral hepatitis possible? (25 min) Wendy Spearman PMTCT for hepatitis B more than just the pregnancy (20 min) Neliswa Gogela Hepatitis E in South Africa (15 min) Tongai Maponga The hidden co-factor with hepatitis B (15 min) Stephen Korsman Unravelling Hepatitis C (20 min) Mark Sonderup Hepatitis A seroprevalence in South Africa. Are we in epidemiological transition? Annabel Enoch Preliminary evaluation of dried blood spots to test for Hepatitis C virus (HCV) antibodies among people who inject drugs, sex workers and men who have sex with men Lucinda Gaelejwe H3D What s new in the antimicrobial R&D pipeline (30 min) Greg Basarab Harnessing developing technology to combat drug resistance (30 min) Richard Gordon New economic models for Research & Development: Lessons from DRIVE-AB (30 min) Stephan Harbath (Switzerland) Re-vitalising the pipeline through the Global Antibiotic Research & Development Partnership (GARDP) (30 min) Manica Balasegaram (Switzerland) Malaria (25 min) Lucille Blumberg Wormy tails (25 min) John Frean PUO in the Tropics (25 min) Helen van der Plas Neglected Tropical Diseases? Cases from the Field (25 min) Rob Davidson (UK) Rabies Virus down-regulates the expression of Actin and Microtubule associated proteins in neurons Waqas Ahmad Coronavirus diversity in South African bats A risk for human health? Wolfgang Preiser Pertussis in South Africa: The modern epidemiology of an old disease (25 min) Ute Hallbauer Role of evidence-based vaccinology in strengthening immunisation programmes (25 min) Benjamin Kagina TB Vaccine (25 min) Willem Hanekom (USA) Vaccines for Rheumatic Fever: The African connection (25 min) Babu Muhamed Meningococcal carriage amongst first-year students on entering University: Is there a need in South Africa for meningococcal prevention strategies? Susan Meiring 12h30 13h30 Lunch Exhibition Areas PLENARY SESSION 5 A Plenary Pot Pourri Chair: Gary Maartens 13h30 14h00 14h00 14h30 14h30 15h00 15h00 15h30 The Genital Microbiome Jacques Ravel (USA) Stowaways: A One Health Perspective Emily Mitchell Advanced HIV and the seriously ill: challenges in low-resource settings Rosie Burton Refreshments Exhibition Areas

7 Saturday 11 November PARALLEL SESSION 4 Hall A Hall B Hall C Meeting Room 11 15h30 17h30 SA 17h30 18h00 Maternal Infections Lindi Masson Ranmini Kularatne The vaginal microbiome during pregnancy and preterm delivery (20 mins) Jacques Ravel (USA) GBS during pregnancy (20 mins) Charlene Africa The timing of antiretroviral therapy (ART) to HIV infected mothers before or during pregnancy has no association with placental inflammation and pathology (20 mins) Clive Gray Maternal infections influence infant gut microbiota and immunity (20 mins) Heather Jaspan Influence of HIV infection on breast Milk microbiome and metabolome (20 mins) Elloise du Toit Prevalence and molecular analysis of Mycoplasma Genitalium strains isolated from pregnant women at an Academic Hospital in Pretoria, South Africa Marcelle le Roux Evaluation of two commercial NAATs for detection of C. trachomatis, N. gonorrhoeae and T. vaginalis in endocervical swabs collected from pregnant women attending the DGMAH Innocent Ngwenya Refreshments Exhibition Areas Fungal Infections Nelesh Govender Graeme Meintjes Global emergence of Candida auris (2) Nelesh Govender Prevention and management of antifungal-resistant infection in the ICU (2) Adrian Brink New antifungal treatment strategies for Cryptococcosis Update from recent clinical trials (2) Graeme Meintjes What s in the diagnostic pipeline for invasive mycoses? (2) Charlotte Sriruttan Independent risk factors associated with Candida auris candidaemia in South Africa An analysis of national surveillance data, Erika van Schalkwyk Diagnostics and New Technologies for Infections Tom Boyles Colleen Bamford Urinary LAM (20 mins) Keertan Dheda Recent advances in diagnostics for active TB (2) Mark Nicol Current and emerging legionella diagnostics (2) Nicole Wolter The performance of Cepheid Xpert HPV (20 mins) Zizipho Mbulawa Molecular characterisation of Salmonella Typhi isolates from South Africa, Nomsa Tau Comparing commercial probiotic and vaginal Lactobacillus strains to evaluate whether probiotics marketed for vaginal health in South Africa are suitable for bacterial vaginosis treatment Anna-Ursula Happel Comparison of nucleic acid amplification tests to detect sexually transmitted infections from virginal specimens Nireshni Mitchev Antibiotic Stewardship - Open papers (SAASP) Dena van den Bergh Andrew Whitelaw Evaluation of colistin utilisation across multiple South African Private Hospitals: Indeed it's time for Colistin Stewardship Angeliki Messina Assessing the impact of Antimicrobial Stewardship ward rounds using an app-based data collection tool in two Public Hospitals in the Eastern Cape, South Africa David Stead Characterising antibiotic-resistant pneumococci in the nasopharynx of healthy South African infants using shotgun sequencing and conventional typing Rendani Manenzhe Knowledge, attitudes and perceptions of Antimicrobial Resistance amongst private practice patients' and prescribers' in South Africa Dena van den Bergh Klebsiella pneumoniae ST307: A silent pathogen on the rise in South Africa Michelle Lowings Navigating the promise of technology in Antibiotic Stewardship Angeliki Messina Antibiotic consumption after two years of Antimicrobial Stewardship ward rounds in the Medicine Department at a Tertiary Hospital in the Eastern Cape Ya-Ying Wang Investigating Antimicrobial Resistance in enteric bacteria within a community setting using a one-health approach Chinyere Okoro ETHICS SESSION Chair: Sipho Dlamini Halls B&C 18h00 18h30 18h30 19h00 19h00 19h00/19h30 The ethics of Antimicrobial use, Antimicrobial Stewardship, and Antibiotic Resistance Charles Feldman The ethics of communication between the Doctor and Patient: The role of social media in facilitating best patient outcomes Gundo Nevhutanda Close of Conference Cape Malay Evening and SA Wine Tasting Century City Hotel, Square Café

7 th FIDSSA CONFERENCE 2017 Programme as at 11 May 2017 PROVISIONAL ACADEMIC PROGRAMME

7 th FIDSSA CONFERENCE 2017 Programme as at 11 May 2017 PROVISIONAL ACADEMIC PROGRAMME THURSDAY 9 NOVEMBER 15h00 17h00 Conference Registration FIDSSA Official Opening Ceremony 17h00 17h15 Welcome & Opening - Marc Mendelson (FIDSSA President) PLENARY SESSION 1: Emerging and Re-Emerging Infectious

More information

GICS sponsorship feedback report

GICS sponsorship feedback report GICS sponsorship feedback report Name GICS number Job / Position Group / Hospital Region Suzette Kruger 278ef36e Infection Prevention Specialist Life Healthcare / Life Dalview Hospital East Date of Conference

More information

FIDSSA Executive Committee

FIDSSA Executive Committee Volume 8, Issue 2 1 st March 2017 FIDSSA Quarterly Newsletter of the Federation of Infectious Diseases Societies of Southern Africa Contents Page 2 Page 3 Page 3 Bloemfontein introduces faecal microbiota

More information

versus CD4. PoC - Messaging - Specificity and - Ethics sensitivity of HIV - Feedback from diagnostic tests demonstration projects

versus CD4. PoC - Messaging - Specificity and - Ethics sensitivity of HIV - Feedback from diagnostic tests demonstration projects PRE-CONFERENCE WORKSHOPS WEDNESDAY, 24 OCTOBER 2018 10h00 14h00 Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop ITREMA trial feedback PrEP for the private

More information

Session 1B - Auditorium Adult cases - Adherence - Mental health - STIs - Opportunistic Infections - TB - Drug Interactions Panel discussion

Session 1B - Auditorium Adult cases - Adherence - Mental health - STIs - Opportunistic Infections - TB - Drug Interactions Panel discussion CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding - Previously on PrEP, now

More information

IP Lab Webinar 8/23/2012

IP Lab Webinar 8/23/2012 2 What Infection Preventionists need to know about the Laboratory Anne Maher, MS, M(ASCP), CIC Richard VanEnk PhD, CIC 1 Objectives Describe what the laboratory can do for you; common laboratory tests

More information

Improving the prevention, diagnosis and clinical management of sepsis

Improving the prevention, diagnosis and clinical management of sepsis SEVENTIETH WORLD HEALTH ASSEMBLY A70/13 Provisional agenda item 12.2 13 April 2017 Improving the prevention, diagnosis and clinical management of sepsis Report by the Secretariat 1. The Executive Board

More information

and the Working Group from the EMBO-AIDS Related Mycoses Workshop Institute of Infectious Disease and Molecular Medicine, University of Cape Town,

and the Working Group from the EMBO-AIDS Related Mycoses Workshop Institute of Infectious Disease and Molecular Medicine, University of Cape Town, 1 AIDS-related mycoses: the way forward Gordon D. Brown 1,2*, Graeme Meintjes 1, Jay K. Kolls 3, Clive Gray 1, William Horsnell 1 and the Working Group from the EMBO-AIDS Related Mycoses Workshop 1 Institute

More information

Outbreak preparedness and the NICD 24-hour hotline a review of calls made to the Hotline, and Outbreak Response Unit, July 2016-June 2017

Outbreak preparedness and the NICD 24-hour hotline a review of calls made to the Hotline, and Outbreak Response Unit, July 2016-June 2017 Outbreak preparedness and the NICD 24-hour hotline a review of calls made to the Hotline, and Outbreak Response Unit, July 2016-June 2017 FIDSSA 2017 Kerrigan McCarthy, Nevashan Govender, Vivien Essel,

More information

Antimicrobial resistance Fact sheet N 194 Updated April 2014

Antimicrobial resistance Fact sheet N 194 Updated April 2014 Antimicrobial resistance Fact sheet N 194 Updated April 2014 Key facts Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by

More information

VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...

VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND... 5 November 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-fourth session Cotonou, Republic of Benin, 3 7 November 2014 Provisional agenda item 11 VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES

More information

COMMUNICABLE DISEASE REPORT

COMMUNICABLE DISEASE REPORT June 2011 Department of Health and Community Services Government of Newfoundland and Labrador COMMUNICABLE DISEASE REPORT Reporting Sexually Transmitted and Bloodborne Infections All laboratory-confirmed

More information

VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...

VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND... 8 April 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH PROGRAMME SUBCOMMITTEE Sixty-fourth session Brazzaville, Republic of Congo, 9 11 June 2014 Provisional agenda item 6 VIRAL HEPATITIS: SITUATION

More information

South Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018

South Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018 South Africa s National HIV Programme Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH 23 October 2018 Overview The HIV and AIDS sub-programme at NDOH is responsible for: policy formulation, coordination,

More information

Strategies to achieve STI control in South Africa Prof Remco Peters

Strategies to achieve STI control in South Africa Prof Remco Peters Strategies to achieve STI control in South Africa Prof Remco Peters 4 th South African HIV Clinicians Society Conference 27th of October 2018 The spectrum of STIs This presentation has been slightly amended

More information

FIDSSA 2017 Congress Abstracts Oral Presentations

FIDSSA 2017 Congress Abstracts Oral Presentations South Afr J Infect Dis 2017 Supp: FIDSSA Oral Presentations Abstracts FIDSSA 2017 Congress Abstracts Oral Presentations ID: 8435 Category: Infection Control (ICSSA) Co-Author 1: Messina, A Co-Author 1

More information

Immunisation in people living with HIV. Dr Bernadett Gosnell, Department of Infectious Diseases, UKZN

Immunisation in people living with HIV. Dr Bernadett Gosnell, Department of Infectious Diseases, UKZN Immunisation in people living with HIV Dr Bernadett Gosnell, Department of Infectious Diseases, UKZN Calculating immunisation s return on investment In Gavi-supported countries, 2011 2020 48x (full income

More information

PRELIMINARY PROGRAMME NHOW MILAN

PRELIMINARY PROGRAMME NHOW MILAN PRELIMINARY PROGRAMME Via Tortona, 35-20144 Milan (Italy) 1 nd SCIENTIFIC PRELIMINARY PROGRAM Thursday, 18 October 2018 OPENING CEREMONY Chairs: M. Clerici (Italy), S. Esposito (Italy), A. Osterhaus (Germany)

More information

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition

More information

SENTINEL SURVEILLANCE OF HUMAN PAPILLOMAVIRUS GENOTYPES AMONG YOUNG WOMEN ATTENDING PUBLIC HEALTHCARE FACILITIES IN SOUTH AFRICA, 2017

SENTINEL SURVEILLANCE OF HUMAN PAPILLOMAVIRUS GENOTYPES AMONG YOUNG WOMEN ATTENDING PUBLIC HEALTHCARE FACILITIES IN SOUTH AFRICA, 2017 SENTINEL SURVEILLANCE OF HUMAN PAPILLOMAVIRUS GENOTYPES AMONG YOUNG WOMEN ATTENDING PUBLIC HEALTHCARE FACILITIES IN SOUTH AFRICA, 2017 Zizipho Mbulawa 1-4, Tendesayi Kufa-Chakezha 2,5, Anna-Lise Williamson

More information

Hepatitis E in South Africa. Tongai Maponga

Hepatitis E in South Africa. Tongai Maponga Hepatitis E in South Africa Tongai Maponga 7th FIDSSA CONGRESS 2017 This is what usually comes to mind History of hepatitis E virus An ET-NANB hepatitis virus later named HEV was first suspected in 1980.

More information

Vaccine Innovation and Adult Immunization Landscape

Vaccine Innovation and Adult Immunization Landscape Vaccine Innovation and Adult Immunization Landscape National Adult and Influenza Immunization Summit, May 12-14, 2015 Phyllis Arthur Senior Director Vaccines, Immunotherapeutics & Diagnostics Policy parthur@bio.org

More information

STI and BV prevalence in young women in Cape Town and Soweto

STI and BV prevalence in young women in Cape Town and Soweto STI and BV prevalence in young women in Cape Town and Soweto Shaun Barnabas Genital Mucosal and STI lab Desmond Tutu HIV Foundation University of Cape Town FAMCRU University of Stellenbosch WISH: Women

More information

Odyssean malaria outbreak at a bush lodge in Madikwe Game Reserve, North West Province, October-November 2015

Odyssean malaria outbreak at a bush lodge in Madikwe Game Reserve, North West Province, October-November 2015 Odyssean malaria outbreak at a bush lodge in Madikwe Game Reserve, North West Province, October-November 2015 Genevie Ntshoe, Andrew Tlagadi, Thejane Motladiile, Kerrigan McCarthy, Oleteng Mokate, John

More information

ANALYSIS OF MYCOPLASMA GENITALIUM STRAINS ISOLATED FROM PREGNANT WOMEN AT AN ACADEMIC HOSPITAL IN PRETORIA, SOUTH AFRICA

ANALYSIS OF MYCOPLASMA GENITALIUM STRAINS ISOLATED FROM PREGNANT WOMEN AT AN ACADEMIC HOSPITAL IN PRETORIA, SOUTH AFRICA ANALYSIS OF MYCOPLASMA GENITALIUM STRAINS ISOLATED FROM PREGNANT WOMEN AT AN ACADEMIC HOSPITAL IN PRETORIA, SOUTH AFRICA Mafunise M 1, Le Roux MC 1, de Villiers BE 1, Ditsele RMM 1,2 1 Department of Microbiological

More information

The Antibiotic Resistance Laboratory Network

The Antibiotic Resistance Laboratory Network The Antibiotic Resistance Laboratory Network 1 Antibiotic Resistance in the United States Sickens >2 million people per year Kills at least 23,000 people each year Plus 15,000 each year from C. difficile

More information

Report on the 3rd International HIV/Viral Hepatitis Co-Infection Meeting

Report on the 3rd International HIV/Viral Hepatitis Co-Infection Meeting Report on the 3rd International HIV/Viral Hepatitis Co-Infection Meeting HIV/Viral Hepatitis: Improving Diagnosis, Antiviral Therapy and Access Tongai Maponga, Rachel Matteau Matsha 22 July 2016 At present,

More information

STIs- REVISION. Prof A A Hoosen

STIs- REVISION. Prof A A Hoosen STIs- REVISION Prof A A Hoosen Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria and the NHLS Microbiology Tertiary Laboratory at the Pretoria Academic Hospital Complex

More information

Saving children and mothers

Saving children and mothers Saving children and mothers child survival & development programme UNICEF South Africa/Blow Fish UNICEF South Africa/Schermbrucker South Africa s progress in healthcare The Statistics Under-five 62/1,000

More information

Product Development for Vaccines Advisory Committee:

Product Development for Vaccines Advisory Committee: Product Development for Vaccines Advisory Committee: Highlights from the 2016 year of vaccine development SAGE, October 2016 David C. Kaslow, MD Chair, Product Development for Vaccines Advisory Committee

More information

Refocussing on STI management to impact HIV prevention

Refocussing on STI management to impact HIV prevention Refocussing on STI management to impact HIV prevention Koleka Mlisana Head: Medical Microbiology (UKZN & NHLS) 14 June 2017: SA AIDS Conference NSP 2017 2022 Objectives Goal 1:Accelerate preventioninorder

More information

Introduction. Infections acquired by travellers

Introduction. Infections acquired by travellers Introduction The number of Australians who travel overseas has increased steadily over recent years and now between 3.5 and 4.5 million exits are made annually. Although many of these trips are to countries

More information

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach Ines Perea Ministry of Health, Germany Reasons for a new strategy in 2016 New international agreements (SDG s) Renewed political

More information

Rashes, Fevers and Infectious Diseases Sydney 2015

Rashes, Fevers and Infectious Diseases Sydney 2015 QRC: 2240 Price One Day : $440 inc. GST Two Days: $660 inc. GST Date 29-30 Jan 2015 Venue Rydges Sydney Central 28 Albion Street, Surry Hills, NW, 2010 CPD Hours 11 Hours 0 Mins Rashes, Fevers and Infectious

More information

The elimination equation: understanding the path to an AIDS-free generation

The elimination equation: understanding the path to an AIDS-free generation The elimination equation: understanding the path to an AIDS-free generation James McIntyre Anova Health Institute & School of Public Health & Family Medicine, University of Cape Town Elimination of perinatal

More information

SOUTH AFRICA S TB BURDEN - OVERVIEW

SOUTH AFRICA S TB BURDEN - OVERVIEW SOUTH AFRICA S TB BURDEN - OVERVIEW Dr Aaron Motsoaledi, MP: Chairperson of the Board, Stop TB Partnership Minister of Health, South Africa 31 January 2014, Cape Town South Africa s TB Burden Global TB

More information

Tuberculosis among public sector healthcare workers in ethekwini District, KwaZulu-Natal

Tuberculosis among public sector healthcare workers in ethekwini District, KwaZulu-Natal ORIGINAL RESEARCH Tuberculosis among public sector healthcare workers in ethekwini District, KwaZulu-Natal S Mahomed 1, DR Khilawan 2, S Knight 2 1 School of Laboratory Medicine and Medical Science, College

More information

AOHS Global Health. Unit 1, Lesson 3. Communicable Disease

AOHS Global Health. Unit 1, Lesson 3. Communicable Disease AOHS Global Health Unit 1, Lesson 3 Communicable Disease Copyright 2012 2016 NAF. All rights reserved. A communicable disease is passed from one infected person to another The range of communicable diseases

More information

Maternal influenza immunisation

Maternal influenza immunisation Maternal influenza immunisation Cheryl Cohen Centre Head Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases cherylc@nicd.ac.za Global causes of death in children

More information

Infection Control in the School Setting. It s In Your Hands

Infection Control in the School Setting. It s In Your Hands Infection Control in the School Setting It s In Your Hands What is an Infection? A condition resulting from the presence of, and invasion by, germs (microorganisms) For Infection to Occur an Organism Must:

More information

Antimicrobial Resistance (AMR) Research & Innovation: Addressing Africa s Regional Priorities Speakers 1 September 2016 Cape Town, South Africa

Antimicrobial Resistance (AMR) Research & Innovation: Addressing Africa s Regional Priorities Speakers 1 September 2016 Cape Town, South Africa Antimicrobial Resistance (AMR) Research & Innovation: Addressing Africa s Regional Priorities Speakers 1 September 2016 Glenda Gray Cape town, South Africa President, SAMRC Glenda Gray is the President

More information

CONTACTS & ACKNOWLEDGEMENTS

CONTACTS & ACKNOWLEDGEMENTS CONTACTS & ACKNOWLEDGEMENTS Snohomish Health District Communicable Disease Surveillance and Response Analysis and publication: Hollianne Bruce, MPH Program Manager: Amy Blanchard, RN, BSN Communicable

More information

Thursday 1 December (The University Club of Western Australia Theatre Auditorium unless otherwise indicated)

Thursday 1 December (The University Club of Western Australia Theatre Auditorium unless otherwise indicated) Thursday 1 December (The University Club of Western Australia Theatre Auditorium unless otherwise indicated) 07:00am - 07:55am (0:55) 08:00am - 08:45am (0:45) 08:50am - 09:20am (0:30) Chair: A/Prof Peter

More information

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( ) Regional Committee for Europe 65th session EUR/RC65/Inf.Doc./3 Vilnius, Lithuania, 14 17 September 2015 2 September 2015 150680 Provisional agenda item 3 ORIGINAL: ENGLISH Global health sector strategies

More information

C O M M U N I C A B L E D I S E A S E S S U R V E I L L A N C E B U L L E T I N V O L U M E 1 2, N O. 4

C O M M U N I C A B L E D I S E A S E S S U R V E I L L A N C E B U L L E T I N V O L U M E 1 2, N O. 4 SURVEILLANCE FOR BORDETELLA PERTUSSIS, ATYPICAL BACTERIAL CAUSES OF PNEUMONIA, HAEMOPHILUS INFLUENZAE AND STREPTOCOCCUS PNEUMONIAE WITHIN THE SEVERE RESPIRATORY ILLNESS SURVEILLANCE PROGRAMME, 2013 Maimuna

More information

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives Martie van der Walt IOM Meeting 15-17 January 2013 introduction 1 min 150 words

More information

Soedarsono Department of Pulmonology & Respiratory Medicine Faculty of Medicine, Universitas Airlangga Dr. Soetomo General Hospital

Soedarsono Department of Pulmonology & Respiratory Medicine Faculty of Medicine, Universitas Airlangga Dr. Soetomo General Hospital Soedarsono Department of Pulmonology & Respiratory Medicine Faculty of Medicine, Universitas Airlangga Dr. Soetomo General Hospital There were an estimated 10.4 million new TB cases in 2015, higher than

More information

FIDSSA Quarterly. April Join our Plenary Speakers THE FEDERATION OF INFECTIOUS DISEASES SOCIETIES OF SOUTHERN AFRICA.

FIDSSA Quarterly. April Join our Plenary Speakers THE FEDERATION OF INFECTIOUS DISEASES SOCIETIES OF SOUTHERN AFRICA. THE FEDERATION OF INFECTIOUS DISEASES SOCIETIES OF SOUTHERN AFRICA Special points of interest: ICID Plenary speakers and registration news 2014 WSAVA Global One Health Award to Prof Lucille Blumberg Tales

More information

Background. Proposed to develop a framework for action. Address by Foreign Minister Koumura

Background. Proposed to develop a framework for action. Address by Foreign Minister Koumura July 2008 Ministry of Foreign Affairs of Japan Background Address by Foreign Minister Koumura Global Health and Japan s Foreign Policy From Okinawa to Toyako (25 November 2007) Special Address by Prime

More information

Public Health Challenges. Identified by Public Health England

Public Health Challenges. Identified by Public Health England Public Health Challenges Identified by Public Health England Environmental Public Health 1. Environmental Change and Health What environmental public health interventions can be identified and developed

More information

Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs

Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs What causes TB? TB is caused by the bacterium Mycobacterium tuberculosis. Although it can cause disease in

More information

Young Mothers: From pregnancy to early motherhood in adolescents with HIV

Young Mothers: From pregnancy to early motherhood in adolescents with HIV Young Mothers: From pregnancy to early motherhood in adolescents with HIV Lisa L. Abuogi, MD, MSc Assistant Professor University of Colorado, Denver 8 th HIV and Women Workshop March 2, 2018 Boston, MA

More information

Microbiological Societies (IUMS) Congress This conference took place in Montreal, CANADA during

Microbiological Societies (IUMS) Congress This conference took place in Montreal, CANADA during (Abroad Domestic)Official trip report form(student) 2014/08/19 (Year/Month/Day) Name Laboratory Year (Grade) Destination Nipawit Karnbunchob Division of Bioinformatics DC2 Montreal, CANADA Period of trip

More information

COMMUNICABLE DISEASES EPIDEMIOLOGIC REPORT

COMMUNICABLE DISEASES EPIDEMIOLOGIC REPORT NEW BRUNSWICK COMMUNICABLE DISEASES EPIDEMIOLOGIC REPORT 2004 COMMUNICABLE DISEASES EPIDEMIOLOGIC REPORT 2004 2 The New Brunswick Communicable Diseases Epidemiologic Report is published by Public Health

More information

14:30-16:30 SATS Council Meeting Venue: Hospitality 25

14:30-16:30 SATS Council Meeting Venue: Hospitality 25 PATS & SATS 2018 CONGRESS 12-15 April 2018, Durban ICC, Sout: Africa Provisional Programme (subject to change) Thursday 12 April 7:00 Registration for pre-congress workshops open Outside workshop venues

More information

Malaria in pregnancy programmes: challenges and priorities in antimalarial drug development for African pregnant women

Malaria in pregnancy programmes: challenges and priorities in antimalarial drug development for African pregnant women 7 th MIM Pan African Malaria Conference 15-20 April 2018 Dakar, Senegal The power of sharing science EDCTP session on Malaria in pregnancy programmes: challenges and priorities in antimalarial drug development

More information

Developing a new drug for Sexually Transmitted Infections

Developing a new drug for Sexually Transmitted Infections Developing a new drug for Sexually Transmitted Infections Emilie Alirol, PhD Antimicrobial Chemotherapy Conference, 15 January 2019 Royal College of Physicians, London Content Global burden of Sexually

More information

Orientation Program for Infection Control Professionals

Orientation Program for Infection Control Professionals Orientation Program for Infection Control Professionals Module 7: Communicable Diseases Table of Contents Module 7: Communicable Diseases... 1 Objectives... 1 Instructions... 1 Overview... 2 Key Concepts...

More information

Activities in 2010, Priorities for 2011

Activities in 2010, Priorities for 2011 European Centre for Disease Prevention and Control Activities in 2010, Priorities for 2011 Presentation to ENVI Committee by Marc Sprenger, Director ECDC 27 October 2010 Part 1: Examples of ECDC s work

More information

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness

More information

Advanced Molecular Detection: An Overview

Advanced Molecular Detection: An Overview Advanced Molecular Detection: An Overview Gregory Armstrong, MD Director Office of Advanced Molecular Detection National Center for Emerging and Zoonotic Infectious Diseases Office of Advanced Molecular

More information

HIV Infection in Pregnancy. Francis J. Ndowa WHO RHR/STI

HIV Infection in Pregnancy. Francis J. Ndowa WHO RHR/STI HIV Infection in Pregnancy Francis J. Ndowa WHO RHR/STI FJN_STI_2005 Department of reproductive health and research Département santé et recherche génésiques Session outline Effect of pregnancy on HIV

More information

2nd World Congress on Infectious and rare disease. September 09-10, 2019 Bangkok, Thailand

2nd World Congress on Infectious and rare disease. September 09-10, 2019 Bangkok, Thailand 2nd World Congress on Infectious and rare disease September 09-10, 2019 Bangkok, Thailand Invitation We cordially invite you all the participants from all over the world to attend 2nd World Congress on

More information

Addressing TB in a High HIV Prevalence Setting in Rural South Africa: the 3Is

Addressing TB in a High HIV Prevalence Setting in Rural South Africa: the 3Is Addressing TB in a High HIV Prevalence Setting in Rural South Africa: the 3Is Yale AIDS Program Section of Infectious Diseases Yale University School of Medicine Sheela Shenoi MD MPH September 20, 2012

More information

SURVEILLANCE FOR GLYCOPEPTIDE-RESISTANT ENTEROCOCCI

SURVEILLANCE FOR GLYCOPEPTIDE-RESISTANT ENTEROCOCCI SURVEILLANCE FOR GLYCOPEPTIDE-RESISTANT ENTEROCOCCI Drs N Bosman, T Nana & C Sriruttan CMID NHLS Dr Charlotte Sriruttan SASCM 3/11 GLOBAL DATA VRE first isolated in Europe in 1987, (Leclercq R., et al

More information

Roche to provide HIV diagnostic solutions to Global Fund. Framework agreement with Global Fund strengthens access to HIV diagnostics

Roche to provide HIV diagnostic solutions to Global Fund. Framework agreement with Global Fund strengthens access to HIV diagnostics Media Release June 18, 2015 Roche to provide HIV diagnostic solutions to Global Fund Framework agreement with Global Fund strengthens access to HIV diagnostics Roche (SIX: RO, ROG; OTCQX: RHHBY) announced

More information

Isolation Precautions in Clinics

Isolation Precautions in Clinics Purpose Audience General principles Possible Exposures To define isolation precautions in a clinic setting. Clinics Isolation status should be determined primarily by the suspected disease and/or pathogen.

More information

PORTFOLIO OF LEARNING

PORTFOLIO OF LEARNING CMSA PORTFOLIO OF LEARNING Certificate in Infectious Diseases of the College of Physicians of South Africa Cert ID(SA) Phys Name: University: HPCSA Training Post Number: Date appointed: PORTFOLIO OF LEARNING

More information

Press Release. Date: 24 March Re: Launch of the Online TB Surveillance Dashboard

Press Release. Date: 24 March Re: Launch of the Online TB Surveillance Dashboard Centre for Tuberculosis 1 Modderfontein Road, Sandringham, 2031 Tel: +27 (0)11 386 6400 Fax: +27 (0)11 882 0596 Reference: WTD-TB Dashboard Press Release Date: 24 March 2017 Re: Launch of the Online TB

More information

COMMUNICABLE DISEASE REPORT Quarterly Report

COMMUNICABLE DISEASE REPORT Quarterly Report COMMUNICABLE DISEASE REPORT Quarterly Report Volume 31, Number 3 December 2014 Healthcare-Associated Infections In past issues of the Communicable Disease Report the focus has been on antibiotic-resistant

More information

Suggested Exercises and Projects 395

Suggested Exercises and Projects 395 Suggested Exercises and Projects 395 Projects These suggested projects are taken in part from the recent book A Course in Mathematical Biology: Quantitative Modeling with Mathematical and Computational

More information

Tuberculosis in children: gaps and opportunities

Tuberculosis in children: gaps and opportunities Tuberculosis in children: gaps and opportunities Mark Nicol Division of Medical Microbiology and Institute for Infectious Diseases and Molecular Medicine, University of Cape Town and National Health Laboratory

More information

HEALTH. Sexual and Reproductive Health (SRH)

HEALTH. Sexual and Reproductive Health (SRH) HEALTH The changes in global population health over the last two decades are striking in two ways in the dramatic aggregate shifts in the composition of the global health burden towards non-communicable

More information

Communicable Diseases Report, NSW, March and April 2012

Communicable Diseases Report, NSW, March and April 2012 Communicable Diseases Report,, March and April 2 Communicable Diseases Branch Department of Health For updated information, including data and facts on specific diseases, visit www.health.nsw.gov.au and

More information

Downloaded from

Downloaded from Class IX: Biology Chapter: Why do we fall ill Chapter Notes Key learnings: 1) Our body s well-being is dependent on the proper functioning of its cells and tissues. 2) All our body parts and activities

More information

WHO: Forum Issue #02 Student Officer Position:

WHO: Forum Issue #02 Student Officer Position: WHO: Topic B Forum : World Health Organization Issue #02 : Topic B: Preparing for a Global Health Crisis Student Officer : Samantha Portillo Position: Chair of the United Nations World Health Organization

More information

SPPH Control of Communicable Diseases January - April 2018

SPPH Control of Communicable Diseases January - April 2018 SPPH 520 - Control of Communicable Diseases January - April 2018 TIME: LOCATION: INSTRUCTORS: OFFICE: ASSISTANT: Mondays, 9:00AM- 12:00PM Room 143, School of Population and Public Health Bldg Dr. David

More information

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in Testimony of the Infectious Diseases Society of America (IDSA) on the Fiscal Year 2018 Department of Health and Human Services Budget Prepared for the U.S. House of Representatives Subcommittee on Labor-HHS-Education

More information

Infection control in aged care facilities 3 rd February 2019

Infection control in aged care facilities 3 rd February 2019 Infection control in aged care facilities 3 rd February 2019 A/Prof. Paul Griffin FRACP, FRCPA, FACTM, AFACHSM, FIML, MBBS, BSc(Hons) Infectious Diseases Physician and Clinical Microbiologist Director

More information

Towards universal access

Towards universal access Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress

More information

How does Gavi make vaccine investment decisions?

How does Gavi make vaccine investment decisions? How does Gavi make vaccine investment decisions? Judith Kallenberg Global Vaccine and Immunization Research Forum Johannesburg, South-Africa, 16 March 2016 www.gavi.org Vaccine Investment Strategy (VIS)

More information

Local Public Health Department. Communicable diseases Environmental health Chronic diseases Emergency preparedness Special programs

Local Public Health Department. Communicable diseases Environmental health Chronic diseases Emergency preparedness Special programs Susan I. Gerber, MD Local Public Health Department Communicable diseases Environmental health Chronic diseases Emergency preparedness Special programs Public Health Reporting Ground Zero Local government

More information

A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES

A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES Since 1888, date of its creation, has been committed to contain infectious diseases by working directly in regions where

More information

Rapid Point-of-Care Tests for STIs: needs, progress, challenges

Rapid Point-of-Care Tests for STIs: needs, progress, challenges Rapid Point-of-Care Tests for STIs: needs, progress, challenges Ranmini Kularatne Centre for HIV and STIs National Institute for Communicable Diseases National Health Laboratory Service South Africa Nov

More information

Public Health, History and Achievements. Dr Faris Al Lami MBChB PhD FFPH

Public Health, History and Achievements. Dr Faris Al Lami MBChB PhD FFPH Public Health, History and Achievements Dr Faris Al Lami MBChB PhD FFPH Objectives Define public health. Describe conditions that existed before the advent of modern public health. Describe important achievements

More information

Preventing & Controlling the Spread of Infection

Preventing & Controlling the Spread of Infection Preventing & Controlling the Spread of Infection Contributors: Alice Pong M.D., Hospital Epidemiologist Chris Abe, R.N., Senior Director Ancillary and Support Services Objectives Review the magnitude of

More information

I mun u i n s i atio i n o n u p u d p a d te

I mun u i n s i atio i n o n u p u d p a d te Immunisation update Brian Eley Paediatric Infectious Diseases Unit Red Cross War Memorial Children s Hospital Department of Paediatrics and Child Health University of Cape Town Immunisation schedules,

More information

Preventing Healthcare-associated Infections in Resource-limited Settings

Preventing Healthcare-associated Infections in Resource-limited Settings Preventing Healthcare-associated Infections in Resource-limited Settings Michael Bell, M.D. Division of Healthcare Quality Promotion Centers for Disease Control and Prevention Challenges for Infection

More information

The emerging threat of multidrug resistant TB: Global and local challenges and solutions

The emerging threat of multidrug resistant TB: Global and local challenges and solutions Summary of IOM-ASSAf Workshop on: The emerging threat of multidrug resistant TB: Global and local challenges and solutions Salim S. Abdool Karim Pretoria - March, 2010 Why this workshop? Why is it on MDR

More information

National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats

National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats Jean B. Patel, PhD, D(ABMM) Science Lead, Antibiotic Resistance and Coordination Unit Centers for

More information

Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA

Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA Technical Advisor, United States Agency for International Development (USAID) Chair, WONCA Working

More information

Version for the Silent Procedure 29 April Agenda item January Hepatitis

Version for the Silent Procedure 29 April Agenda item January Hepatitis Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh

More information

To provide you with the basic concepts of HIV prevention using HIV rapid tests combined with counselling.

To provide you with the basic concepts of HIV prevention using HIV rapid tests combined with counselling. Module 2 Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs Purpose Pre-requisite Modules Learning Objectives To provide you with the basic concepts of HIV prevention using HIV rapid

More information

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary The President s FY 2009 Budget Request for the Centers for Disease Control and Prevention (CDC) discretionary funding is

More information

What s new in Infectious Diseases. Petronella Adomako, MD Infectious Disease Specialist Mckay-Dee Hospital

What s new in Infectious Diseases. Petronella Adomako, MD Infectious Disease Specialist Mckay-Dee Hospital What s new in Infectious Diseases Petronella Adomako, MD Infectious Disease Specialist Mckay-Dee Hospital None Disclosures Objectives New information in infectious diseases. New diseases and outbreaks.

More information

Cervical Cancer Research in South Africa

Cervical Cancer Research in South Africa Gynecologic Cancer InterGroup Cervix Cancer Research Network Cervical Cancer Research in South Africa Lynette Denny Department Obstetrics and Gynaecology, University of Cape Town/ Groote Schuur Hospital

More information

STIs: Practical Aspects of Management

STIs: Practical Aspects of Management STIs: Practical Aspects of Management Dr Heather Young FAChSHM DipPH Christchurch Sexual Health heathery@xtra.co.nz 027 343 4963 Sexually Transmitted Infections BACTERIAL STIs: CHLAMYDIA GONORRHOEA SYPHILIS

More information

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each

More information

The Global Fund & UNICEF Partnership

The Global Fund & UNICEF Partnership The Global Fund & UNICEF Partnership Prof Michel D. Kazatchkine Executive Director UNICEF Executive Board February 9 th, 2011 The Global Fund Millennium Development Goals 1. Eradicate extreme poverty and

More information

MATERNAL AND CHILD SURVIVAL MEMORANDUM OF CONCERN

MATERNAL AND CHILD SURVIVAL MEMORANDUM OF CONCERN MATERNAL AND CHILD SURVIVAL MEMORANDUM OF CONCERN We, the undersigned would like to raise our urgent concerns about the quality and coverage of prevention of mother-to-child transmission of HIV (PMTCT)

More information